JAGX: Jaguar Health Inc

1.63 USD 0.03 (1.87%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do JAGX para hoje mudou para 1.87%. Paralelamente, o preço mais baixo no mercado atingiu 1.58 e o mais alto foi 1.68.

Veja a dinâmica do par de moedas Jaguar Health Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

JAGX Notícias

21:05 Jaguar Health at Emerging Growth Conference 85: Strategic Drug Development Insights
13:08 Jaguar Health to meet with FDA on crofelemer for rare pediatric disease
13:52 Jaguar Health extends Lucid Capital Markets role in ATM agreement to year-end
20:01 Clean Inc. and Sono Group NV at Emerging Growth Conference: Strategic Innovations
13:32 Proof-of-Concept Results Show Jaguar Health’s Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
13:13 Jaguar Health considers cryptocurrency for treasury reserves
13:06 Jaguar Health Board authorizes crypto treasury reserve
13:04 Jaguar Health seeks EU approval for dog diarrhea treatment
20:21 Jaguar Health extends maturity date for $2.57 million in notes
13:48 Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts
14:14 First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
20:28 REMINDER: Jaguar Health to Conduct Fireside Chat 9AM ET June 10 as Part of Lytham Partners’ Spring 2025 Spotlight Series
13:05 Jaguar Health Eyes FDA Orphan Drug Designation for Crofelemer
13:16 Jaguar Health to Conduct Fireside Chat June 10 Regarding Company’s Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners’ Spring 2025 Spotlight Series
12:14 Jaguar Health announces $1.5 million direct offering
13:28 First Patient Randomized in Jaguar Health’s Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID)
18:40 Jaguar Health Reports First Quarter 2025 Financials
13:16 Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates
06:43 Upcoming Stock Splits This Week (March 24 to March 28) – Stay Invested - TipRanks.com
16:01 Why Jaguar Health (JAGX) Stock Is Trading Lower - Jaguar Health (NASDAQ:JAGX)

Faixa diária

1.58 1.68

Faixa anual

0.20 15.48

Fechamento anterior: 1.60
Open: 1.68

Bid: 1.63
Ask: 1.93

Low: 1.58
High: 1.68

Volume: 168

Mudança diária: 1.87%
Mudança mensal: -18.50%

Mudança de 6 meses: 162.90%
Mudança anual: 41.74%

31 agosto, domingo